[ad_1] R289 continues to be generally well tolerated and at doses of ≥500 mg QD preliminary efficacy was observed in elderly, heavily pre-treated lower-risk MDS patients RBC-TI was achieved by 33% (6/18) of evaluable transfusion […]
Trending Stories
MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
[ad_1] NEW YORK, Dec. 7, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, […]
Orna Therapeutics Presents New Data Supporting its in vivo CAR Programs for Autoimmune Diseases and Oncology at the 67th American Society of Hematology Annual Meeting
[ad_1] Anti-CD19 panCARTM program (ORN-252) demonstrated robust B cell depletion with significant reduction in anti-dsDNA titers in humanized lupus model Anti-BCMA panCARTM program showed robust and durable plasma cell depletion in preclinical models Orna expects […]
Studies Point to a Growing Role for New Therapies and Immunotherapies in Treating Blood Cancers
[ad_1] Chemotherapy-free approaches could offer comparable efficacy with less toxicity ORLANDO, Fla., Dec. 7, 2025 /PRNewswire/ — Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as […]
HALLMARK PRESENTS A DISNEY LOVE STORY
[ad_1] TWO ICONIC BRANDS TEAM UP TO CREATE AN UNFORGETTABLE HOLIDAY ADVENTURE LACEY CHABERT AND TRAVIS VAN WINKLE FIND UNEXPECTED MAGIC AND ROMANCE IN HOLIDAY EVER AFTER: A DISNEY WORLD WISH COME TRUE DEBUTING IN […]
